글로벌 세포 분석 시장 (2023-2032) : 소모품, 서비스, 기기, 소프트웨어

■ 영문 제목 : Cell Analysis Market By Product (Consumables, Services, Instruments, Software), By Technique (Flow cytometry, Mass Spectrometry, Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Others), By Application (Oncology, Immunology, Cardiology, Genetic Disease, Stem Cells, Others), By End User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Academic and Research Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Allied Market Research가 발행한 조사보고서이며, 코드는 ALD23SEP108 입니다.■ 상품코드 : ALD23SEP108
■ 조사/발행회사 : Allied Market Research
■ 발행일 : 2023년 4월
■ 페이지수 : 249
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 세계
■ 판매가격 / 옵션 (부가세 10% 별도)
Single UserUSD5,730 ⇒환산￦7,735,500견적의뢰/주문/질문
5 UserUSD6,450 ⇒환산￦8,707,500견적의뢰/주문/질문
Enterprise UserUSD9,600 ⇒환산￦12,960,000견적의뢰/구입/질문
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
세계의 세포 분석 시장은 2022년에 171억 달러로 평가되었으며 2023년부터 2032년까지 9.5%의 연평균 성장률을 보이며 2032년에는 429억 달러에 달할 것으로 예상됩니다. 세포 분석은 개별 세포의 구조, 구성 및 동작을 관찰하고 연구하는 데 사용됩니다. 세포의 건강과 활동에 대한 정보를 얻기 위해 현미경, 유세포 분석, 분광광도법, 면역 분석과 같은 다양한 기술을 사용합니다. 질병을 감지 및 진단하고, 치료에 대한 반응을 모니터링하며, 세포 기능의 메커니즘을 조사하는 데 사용할 수 있습니다.
시장 성장을 이끄는 주요 요인은 세포 분석 기술 발전과 암 및 유전 질환과 같은 만성 질환의 유병률 증가입니다. 예를 들어, 세계보건기구에 따르면 암은 전 세계 주요 사망 원인으로, 2020년에 약 1,000만 명이 암으로 사망했습니다. 2020년에는 유방암이 226만 건으로 가장 많은 건수를 차지했으며, 폐암이 221만 건으로 그 뒤를 이었습니다. 2020년 암 사망의 가장 흔한 원인은 폐암으로 180만 명이 사망했으며, 결장암과 직장암이 91만 6천 건으로 그 뒤를 이었습니다. 또한 제약 및 생명공학 산업에서 R&D 활동이 급증하고 개인 맞춤형 의약품에 대한 관심이 높아지면서 시장 성장이 더욱 촉진되고 있습니다. 그러나 세포 분석 제품의 높은 비용과 숙련된 전문가의 부족은 향후 몇년 동안 시장 성장을 저해 할 것으로 예상됩니다. 반대로 단일 세포 시퀀싱의 높은 성장 잠재력은 예측 기간 동안 시장 성장을위한 수많은 기회를 제공 할 것으로 예상됩니다.

세포 분석 시장은 제품, 애플리케이션, 기술, 최종 용도 및 지역으로 세분화됩니다. 제품별로 시장은 소모품, 소프트웨어, 서비스 및 기기로 나뉩니다. 용도별로 종양학, 면역학, 심장학, 줄기 세포, 유전 질환 및 기타로 구분됩니다. 기술별로 시장은 유세포 분석, 차세대 시퀀싱 (NGS), 중합 효소 연쇄 반응 (PCR), 질량 분석 및 기타로 분류됩니다. 최종 용도를 기준으로 학술 및 연구 실험실, 생명 공학 및 제약 회사, 병원 및 진단 실험실 및 기타로 나뉩니다. 지역별로는 북미, 유럽, 아시아 태평양 및 중남미/중동/아프리카에서 분석됩니다.
이 보고서에서 프로파일링된 주요 기업으로는 Becton, Dickinson and Company, Danaher Corporation, QIAGEN N.V., Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Agilent Technologies, Inc., Sartorius AG, Biomerieux SA, 및 Standard BioTools Inc. 등이 있습니다. 시장에서 활동하는 주요 업체들은 기업 교육 시장 점유율을 확대하기위한 주요 전략으로 제품 출시, 제품 승인 및 협업을 채택했습니다.

이해 관계자를 위한 주요 이점
이 보고서는 2022년부터 2032년까지 세포 분석 시장 분석의 시장 부문, 현재 동향, 추정치 및 역학에 대한 정량적 분석을 제공하여 일반적인 세포 분석 시장 기회를 식별합니다.
시장 조사는 주요 동인, 제약 및 기회와 관련된 정보와 함께 제공됩니다.
포터의 다섯 가지 경쟁 요인 분석은 이해 관계자가 수익 지향적인 비즈니스 결정을 내리고 공급 업체-구매자 네트워크를 강화할 수 있도록 구매자와 공급 업체의 잠재력을 강조합니다.
세포 분석 시장 세분화에 대한 심층 분석은 지배적인 시장 기회를 결정하는 데 도움이 됩니다.
각 지역의 주요 국가는 글로벌 시장에 대한 매출 기여도에 따라 매핑됩니다.
시장 플레이어 포지셔닝은 벤치마킹을 용이하게하고 시장 플레이어의 현재 위치에 대한 명확한 이해를 제공합니다.
이 보고서에는 지역 및 글로벌 세포 분석 시장 동향, 주요 업체, 시장 세그먼트, 응용 분야 및 시장 성장 전략에 대한 분석이 포함되어 있습니다.

주요 시장 부문
기술별
유세포 분석
질량 분석
차세대 시퀀싱(NGS)
중합효소 연쇄 반응(PCR)
기타

용도별
종양학
면역학
심장학
유전 질환
줄기세포
기타

제품별
소모품
서비스
기기
소프트웨어

최종 용도별
생명공학 및 제약 회사
병원 및 진단 실험실
학술 및 연구 실험실
기타

지역별
북미
미국
캐나다
멕시코
유럽
독일
프랑스
영국
이탈리아
스페인
기타 유럽 지역
아시아 태평양
일본
중국
호주
한국
인도
기타 아시아 태평양 지역
중남미/중동/아프리카
브라질
사우디 아라비아
남아프리카 공화국
기타 중동 및 아프리카 지역

주요 기업
○ Agilent Technologies, Inc.
○ Becton, Dickinson and Company
○ Biomerieux SA
○ Bio-Rad Laboratories, Inc. 
○ Danaher Corporation
○ Illumina, Inc.
○ Qiagen N.V.
○ Sartorius AG
○ Standard BioTools Inc.
○ Thermo Fisher Scientific, Inc.
■ 보고서 개요

CHAPTER 1 : 소개
CHAPTER 2 : 개요
CHAPTER 3 : 시장 동향
CHAPTER 4 : 세포 분석 시장, 제품별
CHAPTER 5 : 세포 분석 시장, 기술별
CHAPTER 6 : 세포 분석 시장, 용도별
CHAPTER 7 : 세포 분석 시장, 최종 용도별
CHAPTER 8 : 세포 분석 시장, 지역별
CHAPTER 9 : 경쟁 현황
CHAPTER 10 : 기업 정보

■ 보고서 목차

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence of chronic disease
3.4.1.2. Advancement in cell analysis technology
3.4.1.3. Surge in popularity of personalized medicine approach

3.4.2. Restraints
3.4.2.1. High cost of single cell analysis

3.4.3. Opportunities
3.4.3.1. High growth potential of Single cell sequencing

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: CELL ANALYSIS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Consumables
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Services
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Instruments
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Software
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: CELL ANALYSIS MARKET, BY TECHNIQUE
5.1. Overview
5.1.1. Market size and forecast
5.2. Flow cytometry
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Mass Spectrometry
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Next Generation Sequencing (NGS)
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Polymerase Chain Reaction (PCR)
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Others
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: CELL ANALYSIS MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Oncology
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Immunology
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Cardiology
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. Genetic Disease
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
6.6. Stem Cells
6.6.1. Key market trends, growth factors and opportunities
6.6.2. Market size and forecast, by region
6.6.3. Market share analysis by country
6.7. Others
6.7.1. Key market trends, growth factors and opportunities
6.7.2. Market size and forecast, by region
6.7.3. Market share analysis by country
CHAPTER 7: CELL ANALYSIS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Biotechnology and Pharmaceutical Companies
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Hospitals and Diagnostic Laboratories
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Academic and Research Laboratories
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
7.5. Others
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by region
7.5.3. Market share analysis by country
CHAPTER 8: CELL ANALYSIS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. Market size and forecast, by Product
8.2.3. Market size and forecast, by Technique
8.2.4. Market size and forecast, by Application
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Key market trends, growth factors and opportunities
8.2.6.1.2. Market size and forecast, by Product
8.2.6.1.3. Market size and forecast, by Technique
8.2.6.1.4. Market size and forecast, by Application
8.2.6.1.5. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Key market trends, growth factors and opportunities
8.2.6.2.2. Market size and forecast, by Product
8.2.6.2.3. Market size and forecast, by Technique
8.2.6.2.4. Market size and forecast, by Application
8.2.6.2.5. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Key market trends, growth factors and opportunities
8.2.6.3.2. Market size and forecast, by Product
8.2.6.3.3. Market size and forecast, by Technique
8.2.6.3.4. Market size and forecast, by Application
8.2.6.3.5. Market size and forecast, by End User
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Market size and forecast, by Product
8.3.3. Market size and forecast, by Technique
8.3.4. Market size and forecast, by Application
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Key market trends, growth factors and opportunities
8.3.6.1.2. Market size and forecast, by Product
8.3.6.1.3. Market size and forecast, by Technique
8.3.6.1.4. Market size and forecast, by Application
8.3.6.1.5. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Key market trends, growth factors and opportunities
8.3.6.2.2. Market size and forecast, by Product
8.3.6.2.3. Market size and forecast, by Technique
8.3.6.2.4. Market size and forecast, by Application
8.3.6.2.5. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Key market trends, growth factors and opportunities
8.3.6.3.2. Market size and forecast, by Product
8.3.6.3.3. Market size and forecast, by Technique
8.3.6.3.4. Market size and forecast, by Application
8.3.6.3.5. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Key market trends, growth factors and opportunities
8.3.6.4.2. Market size and forecast, by Product
8.3.6.4.3. Market size and forecast, by Technique
8.3.6.4.4. Market size and forecast, by Application
8.3.6.4.5. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Key market trends, growth factors and opportunities
8.3.6.5.2. Market size and forecast, by Product
8.3.6.5.3. Market size and forecast, by Technique
8.3.6.5.4. Market size and forecast, by Application
8.3.6.5.5. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Key market trends, growth factors and opportunities
8.3.6.6.2. Market size and forecast, by Product
8.3.6.6.3. Market size and forecast, by Technique
8.3.6.6.4. Market size and forecast, by Application
8.3.6.6.5. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Market size and forecast, by Product
8.4.3. Market size and forecast, by Technique
8.4.4. Market size and forecast, by Application
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Key market trends, growth factors and opportunities
8.4.6.1.2. Market size and forecast, by Product
8.4.6.1.3. Market size and forecast, by Technique
8.4.6.1.4. Market size and forecast, by Application
8.4.6.1.5. Market size and forecast, by End User
8.4.6.2. China
8.4.6.2.1. Key market trends, growth factors and opportunities
8.4.6.2.2. Market size and forecast, by Product
8.4.6.2.3. Market size and forecast, by Technique
8.4.6.2.4. Market size and forecast, by Application
8.4.6.2.5. Market size and forecast, by End User
8.4.6.3. Australia
8.4.6.3.1. Key market trends, growth factors and opportunities
8.4.6.3.2. Market size and forecast, by Product
8.4.6.3.3. Market size and forecast, by Technique
8.4.6.3.4. Market size and forecast, by Application
8.4.6.3.5. Market size and forecast, by End User
8.4.6.4. South Korea
8.4.6.4.1. Key market trends, growth factors and opportunities
8.4.6.4.2. Market size and forecast, by Product
8.4.6.4.3. Market size and forecast, by Technique
8.4.6.4.4. Market size and forecast, by Application
8.4.6.4.5. Market size and forecast, by End User
8.4.6.5. India
8.4.6.5.1. Key market trends, growth factors and opportunities
8.4.6.5.2. Market size and forecast, by Product
8.4.6.5.3. Market size and forecast, by Technique
8.4.6.5.4. Market size and forecast, by Application
8.4.6.5.5. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Key market trends, growth factors and opportunities
8.4.6.6.2. Market size and forecast, by Product
8.4.6.6.3. Market size and forecast, by Technique
8.4.6.6.4. Market size and forecast, by Application
8.4.6.6.5. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. Market size and forecast, by Product
8.5.3. Market size and forecast, by Technique
8.5.4. Market size and forecast, by Application
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Key market trends, growth factors and opportunities
8.5.6.1.2. Market size and forecast, by Product
8.5.6.1.3. Market size and forecast, by Technique
8.5.6.1.4. Market size and forecast, by Application
8.5.6.1.5. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Key market trends, growth factors and opportunities
8.5.6.2.2. Market size and forecast, by Product
8.5.6.2.3. Market size and forecast, by Technique
8.5.6.2.4. Market size and forecast, by Application
8.5.6.2.5. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Key market trends, growth factors and opportunities
8.5.6.3.2. Market size and forecast, by Product
8.5.6.3.3. Market size and forecast, by Technique
8.5.6.3.4. Market size and forecast, by Application
8.5.6.3.5. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Key market trends, growth factors and opportunities
8.5.6.4.2. Market size and forecast, by Product
8.5.6.4.3. Market size and forecast, by Technique
8.5.6.4.4. Market size and forecast, by Application
8.5.6.4.5. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2022
CHAPTER 10: COMPANY PROFILES
10.1. Agilent Technologies, Inc.
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.1.7. Key strategic moves and developments
10.2. Becton, Dickinson and Company
10.2.1. Company overview
10.2.2. Key Executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.2.7. Key strategic moves and developments
10.3. Biomerieux SA
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.3.7. Key strategic moves and developments
10.4. Bio-Rad Laboratories, Inc. 
10.4.1. Company overview
10.4.2. Key Executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.4.7. Key strategic moves and developments
10.5. Danaher Corporation
10.5.1. Company overview
10.5.2. Key Executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Business performance
10.5.7. Key strategic moves and developments
10.6. Sartorius AG
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.6.7. Key strategic moves and developments
10.7. Illumina, Inc.
10.7.1. Company overview
10.7.2. Key Executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.7.7. Key strategic moves and developments
10.8. Thermo Fisher Scientific, Inc.
10.8.1. Company overview
10.8.2. Key Executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.9. Qiagen N.V.
10.9.1. Company overview
10.9.2. Key Executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.9.6. Business performance
10.9.7. Key strategic moves and developments
10.10. Standard BioTools Inc.
10.10.1. Company overview
10.10.2. Key Executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
10.10.7. Key strategic moves and developments

LIST OF TABLES
TABLE 01. GLOBAL CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 02. CELL ANALYSIS MARKET FOR CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
TABLE 03. CELL ANALYSIS MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 04. CELL ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
TABLE 05. CELL ANALYSIS MARKET FOR SOFTWARE, BY REGION, 2022-2032 ($MILLION)
TABLE 06. GLOBAL CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 07. CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2022-2032 ($MILLION)
TABLE 08. CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY REGION, 2022-2032 ($MILLION)
TABLE 09. CELL ANALYSIS MARKET FOR NEXT GENERATION SEQUENCING (NGS), BY REGION, 2022-2032 ($MILLION)
TABLE 10. CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION (PCR), BY REGION, 2022-2032 ($MILLION)
TABLE 11. CELL ANALYSIS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. GLOBAL CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 13. CELL ANALYSIS MARKET FOR ONCOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 14. CELL ANALYSIS MARKET FOR IMMUNOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 15. CELL ANALYSIS MARKET FOR CARDIOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 16. CELL ANALYSIS MARKET FOR GENETIC DISEASE, BY REGION, 2022-2032 ($MILLION)
TABLE 17. CELL ANALYSIS MARKET FOR STEM CELLS, BY REGION, 2022-2032 ($MILLION)
TABLE 18. CELL ANALYSIS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 19. GLOBAL CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 20. CELL ANALYSIS MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2022-2032 ($MILLION)
TABLE 21. CELL ANALYSIS MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 22. CELL ANALYSIS MARKET FOR ACADEMIC AND RESEARCH LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 23. CELL ANALYSIS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 24. CELL ANALYSIS MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 25. NORTH AMERICA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 26. NORTH AMERICA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 27. NORTH AMERICA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 28. NORTH AMERICA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. NORTH AMERICA CELL ANALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 30. U.S. CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 31. U.S. CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 32. U.S. CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 33. U.S. CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 34. CANADA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 35. CANADA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 36. CANADA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 37. CANADA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 38. MEXICO CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 39. MEXICO CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 40. MEXICO CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 41. MEXICO CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. EUROPE CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 43. EUROPE CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 44. EUROPE CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 45. EUROPE CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 46. EUROPE CELL ANALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 47. GERMANY CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 48. GERMANY CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 49. GERMANY CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 50. GERMANY CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. FRANCE CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 52. FRANCE CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 53. FRANCE CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 54. FRANCE CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 55. UK CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 56. UK CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 57. UK CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 58. UK CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 59. ITALY CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 60. ITALY CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 61. ITALY CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 62. ITALY CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 63. SPAIN CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 64. SPAIN CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 65. SPAIN CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 66. SPAIN CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. REST OF EUROPE CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 68. REST OF EUROPE CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 69. REST OF EUROPE CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 70. REST OF EUROPE CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 71. ASIA-PACIFIC CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 72. ASIA-PACIFIC CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 73. ASIA-PACIFIC CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 74. ASIA-PACIFIC CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 75. ASIA-PACIFIC CELL ANALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 76. JAPAN CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 77. JAPAN CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 78. JAPAN CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 79. JAPAN CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 80. CHINA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 81. CHINA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 82. CHINA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 83. CHINA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 84. AUSTRALIA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 85. AUSTRALIA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 86. AUSTRALIA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 87. AUSTRALIA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 88. SOUTH KOREA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 89. SOUTH KOREA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 90. SOUTH KOREA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 91. SOUTH KOREA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 92. INDIA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 93. INDIA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 94. INDIA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 95. INDIA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 96. REST OF ASIA-PACIFIC CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 97. REST OF ASIA-PACIFIC CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 98. REST OF ASIA-PACIFIC CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 99. REST OF ASIA-PACIFIC CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 100. LAMEA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 101. LAMEA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 102. LAMEA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 103. LAMEA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 104. LAMEA CELL ANALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 105. BRAZIL CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 106. BRAZIL CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 107. BRAZIL CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 108. BRAZIL CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 109. SAUDI ARABIA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 110. SAUDI ARABIA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 111. SAUDI ARABIA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 112. SAUDI ARABIA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 113. SOUTH AFRICA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 114. SOUTH AFRICA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 115. SOUTH AFRICA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 116. SOUTH AFRICA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 117. REST OF LAMEA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 118. REST OF LAMEA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 119. REST OF LAMEA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 120. REST OF LAMEA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 121. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
TABLE 122. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 123. AGILENT TECHNOLOGIES, INC.: PRODUCT SEGMENTS
TABLE 124. AGILENT TECHNOLOGIES, INC.: SERVICE SEGMENTS
TABLE 125. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 126. AGILENT TECHNOLOGIES, INC.: KEY STRATERGIES
TABLE 127. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
TABLE 128. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 129. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
TABLE 130. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 131. BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
TABLE 132. BIOMERIEUX SA: KEY EXECUTIVES
TABLE 133. BIOMERIEUX SA: COMPANY SNAPSHOT
TABLE 134. BIOMERIEUX SA: PRODUCT SEGMENTS
TABLE 135. BIOMERIEUX SA: PRODUCT PORTFOLIO
TABLE 136. BIOMERIEUX SA: KEY STRATERGIES
TABLE 137. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
TABLE 138. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
TABLE 139. BIO-RAD LABORATORIES, INC. : PRODUCT SEGMENTS
TABLE 140. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
TABLE 141. BIO-RAD LABORATORIES, INC. : KEY STRATERGIES
TABLE 142. DANAHER CORPORATION: KEY EXECUTIVES
TABLE 143. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 144. DANAHER CORPORATION: PRODUCT SEGMENTS
TABLE 145. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 146. DANAHER CORPORATION: KEY STRATERGIES
TABLE 147. SARTORIUS AG: KEY EXECUTIVES
TABLE 148. SARTORIUS AG: COMPANY SNAPSHOT
TABLE 149. SARTORIUS AG: PRODUCT SEGMENTS
TABLE 150. SARTORIUS AG: PRODUCT PORTFOLIO
TABLE 151. SARTORIUS AG: KEY STRATERGIES
TABLE 152. ILLUMINA, INC.: KEY EXECUTIVES
TABLE 153. ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 154. ILLUMINA, INC.: PRODUCT SEGMENTS
TABLE 155. ILLUMINA, INC.: PRODUCT PORTFOLIO
TABLE 156. ILLUMINA, INC.: KEY STRATERGIES
TABLE 157. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
TABLE 158. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 159. THERMO FISHER SCIENTIFIC, INC.: SERVICE SEGMENTS
TABLE 160. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
TABLE 161. QIAGEN N.V.: KEY EXECUTIVES
TABLE 162. QIAGEN N.V.: COMPANY SNAPSHOT
TABLE 163. QIAGEN N.V.: PRODUCT SEGMENTS
TABLE 164. QIAGEN N.V.: PRODUCT PORTFOLIO
TABLE 165. QIAGEN N.V.: KEY STRATERGIES
TABLE 166. STANDARD BIOTOOLS INC.: KEY EXECUTIVES
TABLE 167. STANDARD BIOTOOLS INC.: COMPANY SNAPSHOT
TABLE 168. STANDARD BIOTOOLS INC.: PRODUCT SEGMENTS
TABLE 169. STANDARD BIOTOOLS INC.: PRODUCT PORTFOLIO
TABLE 170. STANDARD BIOTOOLS INC.: KEY STRATERGIES
※본 조사보고서 [글로벌 세포 분석 시장 (2023-2032) : 소모품, 서비스, 기기, 소프트웨어] (코드 : ALD23SEP108) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [글로벌 세포 분석 시장 (2023-2032) : 소모품, 서비스, 기기, 소프트웨어] 에 대해서 E메일 문의는 여기를 클릭하세요.
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

  • 글로벌 협동 로봇 시장 (2023-2032) : 하드웨어, 소프트웨어
    ALD23SEP258 / Allied Market Research / 2023년 6월 / 글로벌 협동 로봇 시장은 2022년 14억 3,000만 달러에서 2023년부터 2032년까지 36.3%의 연평균 성장률로 성장하여 2032년에는 273억 8,000만 달러에 달할 것으로 예상됩니다. 코봇이라고도 불리는 협동 로봇은 공유 작업 공간에서 인간과 협업하여...CHAPTER 1 : 소개 CHAPTER 2 : 개요 CHAPTER 3 : 시장 동향 CHAPTER 4 : 협동 로봇 시장, 구성 요소별 CHAPTER 5 : 협동 로봇 시장, 용도별 CHAPTER 6 : 협동 로봇 시장, 최종 용도별 CHAPTER 7 : 협동 로봇시장, 페이로드 용량별 CHAPTER 8 : 협동 로봇 시장, 지역별...
  • 글로벌 스토리지 냉동 모니터링 시장 (2023-2032) : 소프트웨어, 하드웨어, 서비스
    ALD23SEP251 / Allied Market Research / 2023년 5월 / 글로벌 스토리지 냉동 모니터링 시장은 2022년 8,338.2백만 달러에서 2023년부터 2032년까지 8.0%의 연평균 성장률로 성장하여 2032년에는 17,569.4백만 달러에 달할 것으로 예상됩니다.스토리지 냉동 모니터링은 식품, 의약품 및 기타 온도에 민감한 제품과 같은...CHAPTER 1 : 소개 CHAPTER 2 : 개요 CHAPTER 3 : 시장 동향 CHAPTER 4 : 스토리지 냉동 모니터링 시장, 시스템 유형별 CHAPTER 5 : 스토리지 냉동 모니터링 시장, 구성 요소별 CHAPTER 6 : 스토리지 냉동 모니터링 시장, 저장 용도별 CHAPTER 7 : 스토리지 냉동 모니터링 시장, 최종 용도별 CHAPTER...
  • 글로벌 변전소 자동화 시장 (2023-2032) : 소프트웨어, 하드웨어, 서비스
    ALD23SEP257 / Allied Market Research / 2023년 6월 / 변전소 자동화는 변전소의 모니터링, 제어 및 관리를 향상시키기 위한 첨단 기술과 시스템을 구현하는 것을 말합니다. 변전소는 전력망의 핵심 구성 요소로 전기의 송전, 배전, 변압을 용이하게 합니다. 자동화를 통해 변전소에는 지능형...CHAPTER 1 : 소개 CHAPTER 2 : 개요 CHAPTER 3 : 시장 동향 CHAPTER 4 : 변전소 자동화 시장, 제품별 CHAPTER 5 : 변전소 자동화 시장, 유형별 CHAPTER 6 : 변전소 자동화 시장, 구성 요소 별 CHAPTER 7 : 변전소 자동화 시장, 지역별 CHAPTER 8 : 경쟁 현황 CHAPTER 9...
  • 글로벌 장질환 검사 시장 (2023-2032) : 시약 및 소모품, 기기
    ALD23SEP101 / Allied Market Research / 2023년 4월 / 세계의 장질환 검사 시장은 2022년에 38억 7,060만 달러로 평가되었으며, 2023년부터 2032년까지 3.3%의 연평균 성장률을 보이며 2032년에는 53억 2,360만 달러에 달할 것으로 예상됩니다. 장질환은 박테리아, 바이러스, 기생충 등 다양한 미생물에 의해...CHAPTER 1 : 소개 CHAPTER 2 : 개요 CHAPTER 3 : 시장 동향 CHAPTER 4 : 장질환 검사 시장, 제품 유형별 CHAPTER 5 : 장질환 검사 시장, 기술별 CHAPTER 6 : 장질환 검사 시장, 질환 유형별 CHAPTER 7 : 장질환 검사 시장, 최종 용도별 CHAPTER 8 : 장질환 검사 시장,...
  • 글로벌 교육용 컴퓨터 기기 시장 (2023-2032) : 스마트폰, 노트북, 태블릿, 기타
    ALD23SEP272 / Allied Market Research / 2023년 6월 / 글로벌 교육용 컴퓨터 기기 시장은 2022년 1,013억 달러에서 2023년부터 2032년까지 14.1%의 연평균 성장률로 성장하여 2032년에는 3,681억 달러에 달할 것으로 예상됩니다.휴대폰, 노트북, PC는 실내와 실외 모두에서 효과적인 교육 보조 도구로 발전했습니다....CHAPTER 1 : 소개 CHAPTER 2 : 개요 CHAPTER 3 : 시장 동향 CHAPTER 4 : 교육용 컴퓨터 기기 시장, 제품 유형별 CHAPTER 5 : 교육용 컴퓨터 기기 시장, 최종 용도별 CHAPTER 6 : 교육용 컴퓨터 기기 시장, 지역별 CHAPTER 7 : 경쟁 현황 CHAPTER 8 : 기업 정보...